SG11201810254UA - Blood sample analysis method and system, for determining diabetes - Google Patents
Blood sample analysis method and system, for determining diabetesInfo
- Publication number
- SG11201810254UA SG11201810254UA SG11201810254UA SG11201810254UA SG11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA SG 11201810254U A SG11201810254U A SG 11201810254UA
- Authority
- SG
- Singapore
- Prior art keywords
- blood sample
- sample analysis
- analysis method
- diabetes
- diabetes complications
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7042—Aging, e.g. cellular aging
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016099163 | 2016-05-17 | ||
| PCT/JP2017/018592 WO2017200025A1 (ja) | 2016-05-17 | 2017-05-17 | 糖尿病を判定するための血液試料の分析方法及びシステム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810254UA true SG11201810254UA (en) | 2018-12-28 |
Family
ID=60326004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810254UA SG11201810254UA (en) | 2016-05-17 | 2017-05-17 | Blood sample analysis method and system, for determining diabetes |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190271708A1 (ja) |
| EP (1) | EP3460478A4 (ja) |
| JP (2) | JP6609282B2 (ja) |
| CN (1) | CN109154619A (ja) |
| AU (1) | AU2017266331A1 (ja) |
| IL (1) | IL263024A (ja) |
| SG (1) | SG11201810254UA (ja) |
| WO (1) | WO2017200025A1 (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202016546A (zh) * | 2018-06-07 | 2020-05-01 | 國立大學法人金澤大學 | 腎臟病之疾病狀態生物標記 |
| WO2020080488A1 (ja) * | 2018-10-17 | 2020-04-23 | 株式会社 資生堂 | クリティカル期の腎障害を判定するためのマーカー |
| JPWO2020196436A1 (ja) * | 2019-03-22 | 2020-10-01 | ||
| JPWO2020196437A1 (ja) * | 2019-03-22 | 2020-10-01 | ||
| CN114113349B (zh) * | 2020-08-26 | 2024-01-23 | 湖南农业大学 | 一种基于二维液相色谱-紫外衍生法同时测定生物基质中5种氨基酸类神经递质的方法 |
| WO2022244842A1 (ja) * | 2021-05-19 | 2022-11-24 | Kagami株式会社 | 糖質代謝の調整のための組成物及び、対象の糖質代謝の状態を評価する方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI351278B (en) * | 2002-03-01 | 2011-11-01 | Nisshin Pharma Inc | Agent for preventing and treating of liver disease |
| CA2647122A1 (en) * | 2006-03-24 | 2007-10-04 | Metanomics Gmbh | Means and method for diagnosing diabetes |
| EP1837657A1 (en) * | 2006-03-24 | 2007-09-26 | Metanomics GmbH | Means and method for predicting or diagnosing diabetes |
| US20080026378A1 (en) * | 2006-07-28 | 2008-01-31 | Gian Franco Bottazzo | Prediction and prophylactic treatment of type 1 diabetes |
| WO2008156617A2 (en) * | 2007-06-15 | 2008-12-24 | Smithkline Beecham Corporation | Methods and kits for predicting treatment response in type ii diabetes mellitus patients |
| EP3543691A1 (en) * | 2007-06-29 | 2019-09-25 | Quest Diagnostics Investments Incorporated | Analysis of amino acids in body fluid by liquid chromatography-mass spectrometry |
| WO2011034088A1 (ja) * | 2009-09-16 | 2011-03-24 | 旭化成ファーマ株式会社 | 急性期脳梗塞におけるアテローム血栓性脳梗塞の病型鑑別方法および発症予測方法 |
| JP2011092100A (ja) * | 2009-10-29 | 2011-05-12 | Dna Chip Research Inc | 生理的状態変化と生理的状態に変化を与える要因の効果を評価する遺伝子マーカー、評価方法、評価システム、及びコンピュータプログラム |
| WO2012164525A2 (en) * | 2011-06-01 | 2012-12-06 | Ecole Polytechnique Federale De Lausanne (Epfl) | Aging biomarkers |
| EP2829877B1 (en) * | 2012-03-18 | 2020-01-22 | Shiseido Company, Ltd. | Apparatus, system and method for analyzing disease sample |
| EP2880440B1 (en) * | 2012-07-30 | 2018-10-31 | In Ovo B.V. | Gender, viability and/or developmental stage determination of avian embryos in ovo |
| CN102901789A (zh) * | 2012-09-21 | 2013-01-30 | 中国药科大学 | 糖尿病肾病早期诊断的血清代谢标志物测定方法 |
| EP3321686B1 (en) * | 2013-01-31 | 2024-03-13 | Metabolon, Inc. | Biomarkers related to insulin resistance progression and methods using the same |
| EP3081939B1 (en) * | 2013-12-11 | 2021-02-17 | Kagami Inc. | Marker for early diagnosis of kidney failure |
| JP2017516085A (ja) * | 2014-04-08 | 2017-06-15 | メタボルン インコーポレーティッド | 疾患診断および健康評価のための個々の対象の低分子生化学プロファイリングの方法 |
-
2017
- 2017-05-17 WO PCT/JP2017/018592 patent/WO2017200025A1/ja unknown
- 2017-05-17 AU AU2017266331A patent/AU2017266331A1/en not_active Abandoned
- 2017-05-17 JP JP2017098448A patent/JP6609282B2/ja active Active
- 2017-05-17 SG SG11201810254UA patent/SG11201810254UA/en unknown
- 2017-05-17 EP EP17799449.8A patent/EP3460478A4/en not_active Withdrawn
- 2017-05-17 CN CN201780029197.3A patent/CN109154619A/zh active Pending
- 2017-05-17 US US16/302,235 patent/US20190271708A1/en not_active Abandoned
-
2018
- 2018-11-14 IL IL263024A patent/IL263024A/en unknown
-
2019
- 2019-07-04 JP JP2019125543A patent/JP6884346B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017200025A1 (ja) | 2017-11-23 |
| AU2017266331A1 (en) | 2018-12-06 |
| JP2017207490A (ja) | 2017-11-24 |
| JP2019191192A (ja) | 2019-10-31 |
| JP6884346B2 (ja) | 2021-06-09 |
| JP6609282B2 (ja) | 2019-11-20 |
| US20190271708A1 (en) | 2019-09-05 |
| IL263024A (en) | 2018-12-31 |
| AU2017266331A8 (en) | 2018-12-20 |
| CN109154619A (zh) | 2019-01-04 |
| EP3460478A1 (en) | 2019-03-27 |
| EP3460478A4 (en) | 2020-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810254UA (en) | Blood sample analysis method and system, for determining diabetes | |
| EA201891293A1 (ru) | Мультиспецифические антитела | |
| BR112017004379A2 (pt) | determinação de vivacidade em multi-estágio | |
| EA201891292A1 (ru) | Мультиспецифические антитела | |
| EP3816303A3 (en) | Breast cancer detection kit or device, and method for detecting breast cancer | |
| MX2019003473A (es) | Metodos mejorados para evaluar el estado de ubiquitin carboxi-terminal hidrolasa l1 (uch-l1) en muestras de pacientes. | |
| BR112018069849A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático precoce ou de lesão precursora do câncer pancreático | |
| BR112017018821A2 (pt) | métodos para quantificação de níveis de insulina através de espectrometria de massa | |
| PH12019502558A1 (en) | Diagnostic assays for detecting, quantifying, and/or tracking microbes and other analytes | |
| PH12018550037A1 (en) | Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof | |
| EP3967769A3 (en) | Lung cancer detection kit or device, and detection method | |
| EP3816302A3 (en) | Esophageal cancer detection kit or device, and detection method | |
| MX364886B (es) | Lente oftálmica con sistema microfluídico. | |
| EP3508577A3 (en) | Modified amadoriase capable of acting on fructosyl hexapeptide | |
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| WO2016197183A8 (en) | Method and system for patient and biological sample identification and tracking | |
| SG11201810261UA (en) | Kidney disease prognosis prediction method and system | |
| IN2014CN03508A (ja) | ||
| EA201391627A1 (ru) | Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения | |
| BR112018010764A2 (pt) | método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente | |
| EP2081029A3 (en) | Bio-markers for diagnosing diabetic retinopathy | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
| BR112022008217A2 (pt) | Métodos e dispositivos para sequenciamento | |
| BR112022012329A2 (pt) | Método para detectar uma proteína específica contida em uma vesícula extracelular, agente de tratamento de permeabilização de membrana, e, kit para detectar uma proteína específica contida em uma vesícula extracelular | |
| MX2015015023A (es) | Metodo para la determinacion de cobre libre. |